Raw Materials & Excipients Management – Page 34 – Pharma.Tips

Segregation controls inadequate during investigation – CAPA and system strengthening

Strengthening Segregation Controls During Investigations: A Playbook for Pharma Professionals In the pharmaceutical manufacturing landscape, inadequate segregation controls during investigations can lead to significant compliance issues and potential product contamination.…

FIFO not followed during inventory reconciliation – GMP storage compliance requirements

Identifying the symptoms of FIFO non-compliance during inventory reconciliation is critical. Common signals include:Click to read the full article.

Analytical method sensitivity questioned during regulatory inspection – preventing product recall

Addressing Analytical Method Sensitivity Concerns Identified During Regulatory Inspections In recent regulatory inspections, questions surrounding the sensitivity of analytical methods have led to increased scrutiny of manufacturing processes, particularly in…

Environmental monitoring gaps during deviation investigation – preventing repeat storage deviations

Detecting the early symptoms of environmental monitoring gaps is crucial. Symptoms may arise from various points within the production or storage environment:Click to read the full article.

Regulatory query on nitrosamines during submission support – CAPA for nitrosamine findings

Identifying early warning signals regarding nitrosamine presence is vital. Common symptoms might include:Click to read the full article.

Improper segregation of materials during routine checks – preventing repeat storage deviations

Identifying the symptoms or signals of improper material segregation is critical for initiating an investigation. Common indicators may include:Click to read the full article.

Regulatory query on nitrosamines during supplier audit – risk mitigation and control strategy

Identifying signs of potential nitrosamine contamination during production or laboratory testing is crucial. Symptoms can manifest in various ways, including:Click to read the full article.

Storage condition excursion during routine checks – CAPA for warehouse failures

The first step in identifying a storage condition excursion involves recognizing the symptoms observed on the production floor or in the laboratory. Symptoms can manifest through several signals, including but…

Regulatory query on nitrosamines during risk assessment – risk mitigation and control strategy

Identifying early symptoms or signals indicative of nitrosamine risk is critical in maintaining compliance with regulatory expectations. Key indicators may include:Click to read the full article.

Improper segregation of materials during warehouse operations – preventing repeat storage deviations

Addressing Improper Segregation of Materials in Warehouse Operations to Prevent Storage Deviations In the dynamic environment of pharmaceutical manufacturing, the improper segregation of materials during warehouse operations can lead to…

Nitrosamine risk assessment incomplete during risk assessment – risk mitigation and control strategy

Recognizing the symptoms of an incomplete nitrosamine risk assessment is crucial for early intervention. Here are common signals that can arise during production or laboratory activities:Click to read the full…

Storage condition excursion during inventory reconciliation – inspection defense documentation

Storage condition excursions may manifest through various signals during routine operations. Common indicators include:Click to read the full article.